How can technological innovations enhance the precision of cannabinoid dosing in patients?
How can technological innovations enhance the precision of cannabinoid dosing in patients? Technological innovations can enhance the precision of cannabinoid dosing through advancements in delivery systems, monitoring devices, and personalized medicine approaches. For instance, smart inhalers and transdermal patches equipped with sensors can enable real-time tracking of cannabinoid levels, allowing for more accurate dosing and adjustments based on individual responses. Furthermore, artificial intelligence and machine learning algorithms can analyze patient data to tailor cannabinoid therapies to specific needs and optimize treatment regimens. Such technologies can also facilitate the development of formulations with precise cannabinoid ratios, enhancing therapeutic outcomes while minimizing side effects. Embracing these innovations will be essential for advancing cannabinoid-based therapies and improving patient care (Wang et al., 2021).